These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20799259)

  • 41. Statistical inference for time-to-event data in non-randomized cohorts with selective attrition.
    Wang T; Mao L; Cocco A; Kim K
    Stat Med; 2024 Jan; 43(2):216-232. PubMed ID: 37957033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomization by minimization for unbalanced treatment allocation.
    Han B; Enas NH; McEntegart D
    Stat Med; 2009 Nov; 28(27):3329-46. PubMed ID: 19739238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estimating probit models with self-selected treatments.
    Bhattacharya J; Goldman D; McCaffrey D
    Stat Med; 2006 Feb; 25(3):389-413. PubMed ID: 16382420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regularized estimation in the accelerated failure time model with high-dimensional covariates.
    Huang J; Ma S; Xie H
    Biometrics; 2006 Sep; 62(3):813-20. PubMed ID: 16984324
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases.
    Curtis LH; Hammill BG; Eisenstein EL; Kramer JM; Anstrom KJ
    Med Care; 2007 Oct; 45(10 Supl 2):S103-7. PubMed ID: 17909367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estimating survival and association in a semicompeting risks model.
    Lakhal L; Rivest LP; Abdous B
    Biometrics; 2008 Mar; 64(1):180-8. PubMed ID: 17645782
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival curve estimation with dependent left truncated data using Cox's model.
    Mackenzie T
    Int J Biostat; 2012 Oct; 8(1):. PubMed ID: 23104845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficient analysis of case-control studies with sample weights.
    Landsman V; Graubard BI
    Stat Med; 2013 Jan; 32(2):347-60. PubMed ID: 22833421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A likelihood ratio test for cancer screening trials.
    Self SG; Etzioni R
    Biometrics; 1995 Mar; 51(1):44-50. PubMed ID: 7766795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Marginal estimation for multi-stage models: waiting time distributions and competing risks analyses.
    Satten GA; Datta S
    Stat Med; 2002 Jan; 21(1):3-19. PubMed ID: 11782047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. On corrected score approach for proportional hazards model with covariate measurement error.
    Song X; Huang Y
    Biometrics; 2005 Sep; 61(3):702-14. PubMed ID: 16135021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analyses of cumulative incidence functions via non-parametric multiple imputation.
    Ruan PK; Gray RJ
    Stat Med; 2008 Nov; 27(27):5709-24. PubMed ID: 18712779
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data.
    Shimura M; Gosho M; Hirakawa A
    Stat Med; 2017 Jun; 36(13):2067-2080. PubMed ID: 28211076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A method to estimate the variance of an endpoint from an on-going blinded trial.
    Xing B; Ganju J
    Stat Med; 2005 Jun; 24(12):1807-14. PubMed ID: 15803440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The distribution of loss in two-treatment biased-coin designs.
    Atkinson AC
    Biostatistics; 2003 Apr; 4(2):179-93. PubMed ID: 12925515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mantel-Haenszel-type inference for cumulative odds ratios with a stratified ordinal response.
    Liu IM; Agresti A
    Biometrics; 1996 Dec; 52(4):1223-34. PubMed ID: 8962452
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of confidence interval methods for the intraclass correlation coefficient in cluster randomized trials.
    Ukoumunne OC
    Stat Med; 2002 Dec; 21(24):3757-74. PubMed ID: 12483765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Baseline information in structural failure time estimators for the effect of observed treatment compliance.
    Loeys T; Goetghebeur E
    Stat Med; 2002 May; 21(9):1173-88. PubMed ID: 12111873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bias-adjusted Kaplan-Meier survival curves for marginal treatment effect in observational studies.
    Wang X; Bai F; Pang H; George SL
    J Biopharm Stat; 2019; 29(4):592-605. PubMed ID: 31286838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Weighted re-randomization tests for minimization with unbalanced allocation.
    Han B; Yu M; McEntegart D
    Pharm Stat; 2013; 12(4):243-53. PubMed ID: 23760923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.